Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia
Authors:
- Paula González-JiménezPGPaula González-Jiménez
- Mónica PiquerasMPMónica Piqueras
- Ana LatorreALAna Latorre
- Jordi Tortosa-CarreresJTJordi Tortosa-Carreres
- Noé MengotNMNoé Mengot
- Ricardo AlonsoRARicardo Alonso
- Soledad ReyesSRSoledad Reyes
- Isabel Amara-EloriIAIsabel Amara-Elori
- Luis Martínez-DolzLMLuis Martínez-Dolz
- Antonio MoscardóAMAntonio Moscardó
- Rosario MenéndezRMRosario Menéndez
- Raúl MéndezRMRaúl Méndez
Open Access
- 21 October 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (10) , 2413
Abstract
Background: Complications in community-acquired pneumonia (CAP), including cardiovascular events (CVE), can occur during an acute episode and in the long term. We aimed to analyse the role of endothelial damage biomarkers (C-terminal endothelin-1 precursor fragment [CT-proET-1] and mid-regional pro-adrenomedullin [MR-proADM]), in contrast to classic inflammation markers (C Reactive Protein [CRP] and procalcitonin [PCT]) in patients admitted for CAP and their relationship with ICU admission, CVE and mortality in the short and long term; Methods: Biomarkers were analysed in 515 patients with CAP at day 1, 285 at day 5 and 280 at day 30. Traditional inflammatory biomarkers and endothelial damage biomarkers were measured. ICU admission, CVE and mortality (in-hospital and 1-year follow-up) were assessed using receiver operating characteristic (ROC) curve analysis and univariate logistic regression. Results: A statistically significant association was observed between initial, raised CT-proET-1 and MR-proADM levels, the need for ICU admission and the development of in-hospital CVE or in-hospital mortality. Both endothelial markers maintained a strong association at day 30 with 1-year follow-up CVE. At day 1, CRP and PCT were only associated with ICU admission. On day 30, there was no association between inflammatory markers and long-term CVE or death. The odds ratio (OR) and area under the curve (AUC) of endothelial biomarkers were superior to those of classic biomarkers for all outcomes considered. Conclusions: Endothelial biomarkers are better indicators than classic ones in predicting worse outcomes in both the short and long term, especially CVE. MR-proADM is the best biomarker for predicting complications in CAP.Keywords
Funding Information
- Sociedad Española de Neumología y Cirugía Torácica (914/2019, 2018 y 2019, 2020-282-01, CM23/00062, ISCIII JR21/00051, 2023-875-1)
- Sociedad Valenciana de Neumología (SVN) (914/2019, 2018 y 2019, 2020-282-01, CM23/00062, ISCIII JR21/00051, 2023-875-1)
- Menarini S.A. (914/2019, 2018 y 2019, 2020-282-01, CM23/00062, ISCIII JR21/00051, 2023-875-1)
- Instituto de Salud Carlos III (914/2019, 2018 y 2019, 2020-282-01, CM23/00062, ISCIII JR21/00051, 2023-875-1)
- Health Research Institute La Fe (914/2019, 2018 y 2019, 2020-282-01, CM23/00062, ISCIII JR21/00051, 2023-875-1)
This publication has 27 references indexed in Scilit:
- Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac BiomarkersChest, 2019
- Adrenomedullin in Heart Failure: Pathophysiology and Therapeutic ApplicationEuropean Journal of Heart Failure, 2018
- Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumoniaJournal of Infection, 2015
- Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular DiseaseJAMA, 2015
- Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scoresEnfermedades Infecciosas y Microbiología Clínica, 2014
- Acute pneumonia and the cardiovascular systemThe Lancet, 2013
- Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR®Clinical Biochemistry, 2009
- C-Reactive Protein Is an Independent Predictor of Severity in Community-acquired PneumoniaThe American Journal of Medicine, 2008
- Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart FailureJournal of Cardiac Failure, 2007
- Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trialThe Lancet, 2004